World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
40093
World Ranking
5821
National Ranking
3123

Overview

Robert A. Hauser is affiliated with the University of South Florida in the United States. Their research focus primarily lies within the field of Medicine, with a specialization in Neurology. Their work also extends to Psychiatry and Mental Health, Oncology, Pediatrics, Perinatology and Child Health, and Cognitive Neuroscience.

The scientist's main areas of study include Parkinson's Disease mechanisms and treatments, neurological disorders and treatments, botulinum toxin and related neurological disorders, cancer treatment and pharmacology, restless legs syndrome research, epilepsy research and treatment, and schizophrenia research and treatment.

Frequent publication venues for their research include:

  • Neurology
  • Parkinsonism & Related Disorders
  • CNS Spectrums
  • Clinical Parkinsonism & Related Disorders
  • Movement Disorders

Robert A. Hauser has collaborated extensively with several co-authors, notably:

  • Stuart Isaacson
  • Hubert H. Fernandez
  • Stewart A. Factor
  • Joohi Jimenez-Shahed
  • Mark Forrest Gordon

Among recent research publications are:

  • Trial of Prasinezumab in Early-Stage Parkinson's Disease, 2022, New England Journal of Medicine
  • Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial, 2022, The Lancet Neurology
  • Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression, 2021, JAMA
  • Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease, 2020, JAMA Neurology
  • Medical Management and Prevention of Motor Complications in Parkinson's Disease, 2020, Neurotherapeutics

Best Publications

  • Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

    Jeffrey H Kordower;Yaping Chu;Robert A Hauser;Thomas B Freeman

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's Disease

    J H Kordower;T B Freeman;B J Snow;F J Vingerhoets

  • A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

    C. Warren Olanow;Olivier Rascol;Robert Hauser;Paul D. Feigin

  • Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

    Alan L Whone;Ray L Watts;A Jon Stoessl;Margaret Davis

  • A controlled trial of rasagiline in early Parkinson disease: The tempo study

    Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz

  • The Parkinson's progression markers initiative (PPMI): establishing a PD biomarker cohort

    Kenneth Marek;Sohini Chowdhury;Andrew Siderowf;Shirley Lasch

  • High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor

    Koller W;Pahwa R;Busenbark K;Hubble J

  • Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease

    Thomas B. Freeman;C. Warren Olanow;Robert A. Hauser;G. Michael Nauert

  • Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.

    T. A. Zesiewicz;T. A. Zesiewicz;R. Elble;E. D. Louis;R. A. Hauser

  • The effect of deprenyl and levodopa on the progression of Parkinson's disease

    C W Olanow;R A Hauser;L Gauger;T Malapira

  • Long-term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease

    R A Hauser;T B Freeman;B J Snow;M Nauert

  • Long-term evaluation of deep brain stimulation of the thalamus.

    Rajesh Pahwa;Kelly E. Lyons;Steven B. Wilkinson;Richard K. Simpson

  • Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

    Ju-Hee Kang;Ju-Hee Kang;David J. Irwin;Alice S. Chen-Plotkin;Andrew Siderowf

  • Ropinirole for the treatment of early Parkinson's disease

    C. H. Adler;K. D. Sethi;R. A. Hauser;T. L. Davis

  • A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.

    Robert A. Hauser;Jeffrey Friedlander;Theresa A. Zesiewicz;Charles H. Adler

  • Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD

    Robert A. Hauser;Jean P. Hubble;Daniel D. Truong

  • Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

    J H Kordower;T B Freeman;E Y Chen;E J Mufson

  • A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit

    M Flint Beal;David Oakes;Ira Shoulson

  • Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology

    Thomas B. Freeman;Francesca Cicchetti;Robert A. Hauser;Terrence W. Deacon

Frequent Co-Authors

Rajesh Pahwa
Rajesh Pahwa University of Kansas
Hubert H. Fernandez
Hubert H. Fernandez Cleveland Clinic
Caroline M. Tanner
Caroline M. Tanner University of California, San Francisco
Stewart A. Factor
Stewart A. Factor Emory University
Joseph Jankovic
Joseph Jankovic Baylor College of Medicine
Thomas B. Freeman
Thomas B. Freeman University of South Florida
Werner Poewe
Werner Poewe Innsbruck Medical University
Anthony E. Lang
Anthony E. Lang University of Toronto
Paolo Barone
Paolo Barone University of Salerno
Kelly E. Lyons
Kelly E. Lyons University of Kansas

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have more options than ever before to launch or advance their careers through online programs. Whether your goal is direct patient care or a specialized administrative role, online degrees and certifications offer both flexibility and affordability.

For those interested in healthcare administration, health information technology programs online provide in-demand skills for managing patient data and health records. If you prefer working behind the scenes, billing and coding classes online prepare you for rewarding roles in medical billing, insurance, and coding—all essential to the healthcare system.

Nursing careers also offer robust online pathways. Many students explore the cheapest online fnp programs to become Family Nurse Practitioners (FNPs), opening doors to advanced practice and higher earning potential. If you're exploring registered nursing, you might be wondering how much is online nursing school—these programs can fit a variety of budgets and schedules.

Each pathway offers unique career opportunities, so consider your interests, educational background, and future goals when choosing the right program for you.

Best Scientists Citing Robert A. Hauser

Trending Scientists